Sunbelt Securities’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Sunbelt Securities's XBI Position: Q1 2026 in Review
Sunbelt Securities reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 99% in Q1 2026, selling an estimated $11.7K and leaving 1 share worth $128. The position accounts for ﹤0.01% of the portfolio, ranked #2600.
Sunbelt Securities first reported a position in XBI in Q2 2018 and has held it in 23 quarters since. The position peaked at $383K in Q3 2020. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Sunbelt Securities held 1 share of State Street SPDR S&P Biotech ETF worth $128 as of Q1 2026.
- Sunbelt Securities sold 94 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $11.7K.
- State Street SPDR S&P Biotech ETF made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2600 holding.
- Sunbelt Securities first reported a position in State Street SPDR S&P Biotech ETF in Q2 2018 and has held it in 23 quarters since.
- Sunbelt Securities's State Street SPDR S&P Biotech ETF position peaked at $383K in Q3 2020.
- 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.